ASX · TCL.AX
Transurban Group
A$13.97+A$0.26 (+1.9%)
Transurban Group’s quoted price sits in the lower half of its reported 52-week range, 10.56% below the high.
Loading market information…
ASX · ALQ.AX · AUD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 11:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
ALS Limited’s quoted price sits in the lower half of its reported 52-week range, 20.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ALS Limited’s forward annual dividend is A$0.46 per share, paid semi-annual. The forward yield is 2.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
ALS Limited’s next earnings report is currently expected on Nov 23, 2026, with estimated earnings per share of A$0.41. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow ALS Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Middle East, North Africa, and the Americas. The organization structures its operations into three core divisions: Life Sciences, Commodities, and Industrial. The Commodities division supports mining and mineral exploration firms by providing a comprehensive suite of services, including assaying, analytical testing, and metallurgy. These offerings cover geochemistry, metallurgy, inspection, and ensuring coal quality standards. Throughout the entire resource lifecycle, from initial exploration and feasibility studies to optimization, production, design, development, trade, and rehabilitation, this segment offers critical testing and advisory solutions. Furthermore, it handles coal sampling, analysis, certification, and evaluations of geological formations, alongside other associated analytical tests. The Life Sciences division focuses on the environmental, food, pharmaceutical, and consumer product sectors, delivering analytical testing, sampling, and remote monitoring. It conducts microbiological, physical, and chemical analyses. Moreover, this segment furnishes crucial analytical data to support consulting and engineering companies, various industries, and governmental bodies. The Industrial segment provides specialized diagnostic testing and engineering solutions tailored for the energy, resources, transportation, and infrastructure industries. It caters to a broad clientele, including asset owners, operational managers, construction firms, and equipment manufacturers across sectors such as power generation, petrochemicals, mining, mineral processing, water management, infrastructure development, and transportation. Established in 1863, the company, originally known as Campbell Brothers Limited, adopted its current name, ALS Limited, in August 2012. Its global operations are directed from its headquarters in Milton, Australia.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 29, 2026, 11:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2024 |
|---|
| Mar 25, 2024 |
| A$0.27-14.34% vs estimate |
| A$1.22B-1.09% vs estimate |
| Q4 2023 | May 30, 2023 | A$0.27-15.37% vs estimate | A$1.09B-56.87% vs estimate |
|---|
| Q4 2023 | May 28, 2023 | A$0.33+3.29% vs estimate | A$1.16B-6.15% vs estimate |
|---|
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$13.97+A$0.26 (+1.9%)
Transurban Group’s quoted price sits in the lower half of its reported 52-week range, 10.56% below the high.
A$21.29+A$0.32 (+1.53%)
Brambles Limited’s quoted price sits in the upper half of its reported 52-week range, 16.28% below the high.
A$40.81+A$0.87 (+2.18%)
SGH Limited’s quoted price sits in the lower half of its reported 52-week range, 21.5% below the high.
A$8.83+A$0.15 (+1.67%)
Qantas Airways Limited’s quoted price sits in the lower half of its reported 52-week range, 20.47% below the high.
A$59.20+A$0.26 (+0.44%)
Codan Limited’s quoted price sits in the upper half of its reported 52-week range, 15.33% below the high.
A$16.97+A$1.21 (+7.68%)
Reece Limited’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
A$3.33+A$0.03 (+0.91%)
Imdex Limited’s quoted price sits in the lower half of its reported 52-week range, 27.45% below the high.
A$2.16+A$0.04 (+1.65%)
XRF Scientific Limited’s quoted price sits in the upper half of its reported 52-week range, 4.65% below the high.
